ADVANTECH CAPITAL
Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.
ADVANTECH CAPITAL
Social Links:
Industry:
Finance Financial Services
Founded:
2016-01-01
Status:
Active
Contact:
(852) 2801 6988
Email Addresses:
[email protected]
Technology used in webpage:
Apache HiChina DNS
Similar Organizations
Apis Partners
Apis Partners is a private equity asset manager focused on Financial Services in Growth Markets.
Azure Capital Partners
Azure Capital Partners is a venture capital firm specializing in early-stage and growth capital investments.
GP Capital
Shanghai GP Capital is a private equity firm focused on funding financial services companies.
Legend Capital
Legend Capital, a subsidiary of Legend Holdings Ltd., has a mission to become a top-notch venture capital investor in China.
Pagoda Investment
Pagoda Investment is a private equity firm specializing in growth capital and buyouts in China's TMT.
Sinovation Ventures
Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-11 | ELITE Technology | Advantech Capital investment in Series C - ELITE Technology | N/A |
| 2022-01-05 | CureGenetics | Advantech Capital investment in Series B - CureGenetics | 60 M USD |
| 2022-01-04 | Mojo Vision | Advantech Capital investment in Series B - Mojo Vision | 45 M USD |
| 2021-12-06 | Innoforce Pharmaceuticals | Advantech Capital investment in Series A - Innoforce Pharmaceuticals | 375 M CNY |
| 2021-11-29 | Ablaze Pharmaceuticals | Advantech Capital investment in Series A - Ablaze Pharmaceuticals | 75 M USD |
| 2021-11-08 | Zhimeng Biopharma | Advantech Capital investment in Series B - Zhimeng Biopharma | 350 M CNY |
| 2021-10-01 | Boan Biotech | Advantech Capital investment in Series B - Boan Biotech | 120.9 M CNY |
| 2021-06-17 | Zhuanzhuan | Advantech Capital investment in Series D - Zhuanzhuan | 100 M USD |
| 2021-06-17 | Onconano Medicine | Advantech Capital investment in Series B - Onconano Medicine | 50 M USD |
| 2021-06-03 | Stemirna | Advantech Capital investment in Venture Round - Stemirna | 1.2 B CNY |